Biomarker company NeoProteomics, a spinoff from Case Western Reserve University, has received a $300,000 grant from the National Institutes of Health. NeoProteomics will use the funding to further refine its bioinformatics software, which is used by clients in the research industry to develop and discover new biomarkers for disease, according to a statement from Case. […]
A bioinformatics spinoff company from Case Western Reserve University has reached an exclusive option agreement to license technology from the university. The company, NeoProteomics, was co-founded by Mark Chance, director of Case Center for Proteomics and Bioinformatics. NeoProteomics focuses on the identification and validation of biomarkers, proteins in the blood that can indicate the presence […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Mark Chance learned to love science by hanging around the University of Pennsylvania laboratory of his uncle, Britton Chance. Yesterday, Mark Chance, a physiology and biophysics professor at Case Western Reserve University School of Medicine, accepted $25,000 grant from the Innovation Fund of the Lorain County Community College Foundation for commercializatio efforts of his company, NeoProteomics Inc. Chance belongs to a generation of academic researchers who believe their discoveries find their highest purpose in helping patients.